申请人:UNIV TEXAS
                            
                            
                                公开号:WO2012065139A2
                            
                            
                                公开(公告)日:2012-05-18
                            
                            The invention provides methods and pharmaceutical compositions for treating cancer or promoting apoptosis of cancer cells, or reducing the resistance of cancer cells to chemotherapy or apoptosis-promoting therapies by contacting the cancer cells with an ENTPD5-specific inhibitor.